Cite
Abstract 12727: The Clinical Impact of Eicosapentaenoic Acid/Arachidonic Acid Ratio in Adult Patients With Congenital Heart Disease
MLA
Miki Kanoh, et al. “Abstract 12727: The Clinical Impact of Eicosapentaenoic Acid/Arachidonic Acid Ratio in Adult Patients With Congenital Heart Disease.” Circulation, vol. 132, Nov. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........7e6cf23089c2264a51e4957651b475b0&authtype=sso&custid=ns315887.
APA
Miki Kanoh, Kei Inai, Eriko Shimada, Tokuko Shinohara, Mikiko Shimizu, Tetsuko Ishii, Hisashi Sugiyama, & In-Sam Park. (2015). Abstract 12727: The Clinical Impact of Eicosapentaenoic Acid/Arachidonic Acid Ratio in Adult Patients With Congenital Heart Disease. Circulation, 132.
Chicago
Miki Kanoh, Kei Inai, Eriko Shimada, Tokuko Shinohara, Mikiko Shimizu, Tetsuko Ishii, Hisashi Sugiyama, and In-Sam Park. 2015. “Abstract 12727: The Clinical Impact of Eicosapentaenoic Acid/Arachidonic Acid Ratio in Adult Patients With Congenital Heart Disease.” Circulation 132 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........7e6cf23089c2264a51e4957651b475b0&authtype=sso&custid=ns315887.